Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Could First EU Implementing Acts Threaten Timely Designation Of Notified Bodies?

Executive Summary

While there has been no official public reaction to the first draft implementing acts linked to the new EU Medical Device and IVD Regulations, background discussion points to considerable anger and frustration – in particular, with a document that sets out codes for notified body designation for IVD oversight.

You may also be interested in...



EU Commission Issues A Last-Minute Implementing Regulation For Notified Bodies

Some 20 notified bodies were due to apply for designation under the EU's new Medical Device and IVD Regulations on November 26, and more after. The European Commission published needed codes for the process just one day before the application process began. Could that have created a hold up?

EU Commission May Be Swamped As Notified Bodies Race To Start Line

It is nearly six months since the EU's Medical Device and IVD Regulations entered into force. In 10 days' time, on Nov. 26, notified bodies can apply to be designated under the new rules. More are ready than expected. Can the European Commission cope?

Notified Body Codes: EU Commission Needs To Act Fast

New codes that indicate the scope of notified bodies under the new EU regulations are nearly ready. Will the first implementing act be out on November 26?

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel